日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Impact of Real-Time Continuous Glucose Monitoring on Medication Use and Glycemic Control in Type 2 Diabetes Across Therapy Regimens

实时连续血糖监测对2型糖尿病不同治疗方案中药物使用和血糖控制的影响

Liu, Blake C L; Hannah, Katia L; Nemlekar, Poorva M; Green, Courtney R; Norman, Gregory J

Exploring Combined Use of Continuous Glucose Monitoring and Anti-Diabetes Medications on Glycaemic Control for People With Type 2 Diabetes Not Using Insulin

探讨持续血糖监测与抗糖尿病药物联合应用对未使用胰岛素的2型糖尿病患者血糖控制的影响

Nemlekar, Poorva M; Hannah, Katia L; Green, Courtney R; Norman, Gregory J

Reduction in Diabetes-Related Hospitalizations and Medical Costs After Dexcom G6 Continuous Glucose Monitor Initiation in People with Type 2 Diabetes Using Intensive Insulin Therapy

在接受强化胰岛素治疗的2型糖尿病患者中,启动Dexcom G6连续血糖监测后,糖尿病相关住院率和医疗费用均有所降低

Hannah, Katia L; Nemlekar, Poorva M; Green, Courtney R; Norman, Gregory J

Continuous Glucose Monitoring and Reduced Diabetes-Related Hospitalizations in Patients with Type 2 Diabetes and CKD

持续血糖监测可降低2型糖尿病合并慢性肾病患者的糖尿病相关住院率

Hannah, Katia L; Nemlekar, Poorva M; Johnson, Matthew L; Cherñavvsky, Daniel R; Norman, Gregory J

Association Between Adherence, A1C Improvement, and Type of Continuous Glucose Monitoring System in People with Type 1 Diabetes or Type 2 Diabetes Treated with Intensive Insulin Therapy

依从性、糖化血红蛋白A1C改善情况与接受强化胰岛素治疗的1型糖尿病或2型糖尿病患者的持续血糖监测系统类型之间的关联

Nemlekar, Poorva M; Hannah, Katia L; Green, Courtney R; Norman, Gregory J

Association Between Change in A1C and Use of Professional Continuous Glucose Monitoring in Adults With Type 2 Diabetes on Noninsulin Therapies: A Real-World Evidence Study

非胰岛素治疗的2型糖尿病成人患者中,糖化血红蛋白A1C变化与专业连续血糖监测使用情况之间的关联:一项真实世界证据研究

Nemlekar, Poorva M; Hannah, Katia L; Norman, Gregory J